Physician profile
Sovrin Shah
NPI 1245211663
$13,943.15
in general payments reported to CMS, 2019-2025
43 companies · $2,767 in 2025
The $2,767 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,182 · 2020: $571 · 2021: $1,126 · 2022: $494 · 2023: $3,075 · 2024: $2,729 · 2025: $2,767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,953 · Travel and Lodging: $518 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,952.88 |
| Travel and Lodging | $518.12 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,225.72 | 2019-2024 | Solyx Sis System |
| Procept Biorobotics Corporation | $2,221.99 | 2023-2025 | Aquabeam Robotic System, Aquabeam, Aquabeam System |
| Medtronic, INC. | $1,250.10 | 2023-2025 | Interstim, Altaviva |
| Edap Technomed INC | $1,169.00 | 2023-2024 | |
| Axonics, INC. | $1,024.96 | 2020-2024 | Bulkamid, Axonics |
| Coloplast Corp | $787.89 | 2019-2025 | Altis |
| Medtronic USA, INC. | $517.56 | 2019-2020 | |
| Abc Home Medical Supply, INC. | $407.21 | 2022-2025 | |
| Janssen Biotech, INC. | $392.22 | 2020-2025 | Erleada, Akeega, Balversa |
| Femselect INC. | $360.15 | 2023-2025 | Enplace |
| Bayer Healthcare Pharmaceuticals INC. | $240.72 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $218.47 | 2022-2025 | Pylarify |
| Teleflex LLC | $203.83 | 2021-2025 | Barrigel |
| Sumitomo Pharma America, INC. | $186.35 | 2023-2025 | Orgovyx, Gemtesa |
| Hollister Incorporated | $162.77 | 2022-2024 | Infyna Chic, Vapro, Vapro Pocket |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $157.84 | 2023 | Botox |
| Urogen Pharma, INC. | $148.12 | 2022-2025 | Jelmyto |
| Astellas Pharma US INC | $120.74 | 2023-2025 | Xtandi, Myrbetriq |
| Valencia Technologies Corporation | $102.29 | 2024 | Ecoin Device Kit |
| Caldera Medical, INC | $101.91 | 2025 | |
| Laborie Medical Technologies Corp. | $99.47 | 2024-2025 | Optilume Urethral Drug Coated Balloon, Optilume Bph Drug Coated Balloon Catheter |
| Renovia INC | $93.90 | 2019 | |
| Shockwave Medical, INC | $70.66 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $67.32 | 2025 | Scopis Ent |
| Koelis INC. | $58.29 | 2023 | |
| Tolmar, INC. | $56.94 | 2024-2025 | Eligard |
| Urovant Sciences INC | $44.75 | 2021 | |
| Olympus America INC. | $43.73 | 2020-2024 | Itind System |
| Myovant Sciences INC. | $41.11 | 2022 | |
| Allergan, INC. | $37.84 | 2019 | |
| Antares Pharma, INC. | $35.49 | 2022 | |
| Endo USA, INC. | $35.39 | 2025 | Xiaflex, Aveed |
| Janssen Scientific Affairs, LLC | $33.38 | 2019 | |
| Blue Earth Diagnostics | $29.75 | 2023 | |
| Dentsply Ih Ab | $28.40 | 2025 | Lofric |
| Merck Sharp & Dohme LLC | $26.64 | 2024 | Keytruda |
| Rochester Medical Corporation | $24.54 | 2020 | |
| Verity Pharmaceuticals INC. | $24.26 | 2024 | Tlando |
| Integra Lifesciences Corporation | $20.85 | 2023 | Integra, Omnigraft, Surgimend |
| Profound Medical Corp. | $20.45 | 2025 | Tulsa-Pro |
| Dentsply Ih INC. | $19.33 | 2021 | |
| Sagent Pharmaceuticals | $17.71 | 2021 | |
| Neotract INC. | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sovrin Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.